Top Industry Leaders in the North America Drug Screening Market
Latest North America Drug Screening Companies Updates:
Laboratory Corporation of America Holdings (LabCorp) In August 2023, LabCorp acquired certain laboratory testing assets of Quest Diagnostics in the US, strengthening its position in the drug screening market.
Eurofins Scientific In November 2023, Eurofins acquired ChemWerth, a US-based Contract Research Organization (CRO) specializing in toxicology and drug development, gaining a foothold in the North American market.
Roche Diagnostics Launched the Cobas® Infinity U 11, a high-throughput instrument for automated urine drug screening, offering faster and more efficient testing.
Becton, Dickinson and Company (BD) Received FDA approval for its BD Veritor™ Plus rapid test for fentanyl in saliva, addressing the growing opioid crisis.EMN Medical Technologies: Developed a novel urine dipstick test for rapid detection of multiple drugs of abuse, aiming for portability and immediate results.
List of North America Drug Screening Key companies in the market:
- Siemens Healthnieers
- Laboratory Corporation of America Holdings
- Quest Diagnostics
- Roche Diagnostics
- Thermo Fisher Scientific, Inc.
- Express Diagnostics Int'l Inc.
- Shimadzu
- MPD, Inc.
